In Vitro Diagnostics Market

In Vitro Diagnostics Market (Product & Service: Reagents & Kits, Instruments, and Software & Services; and Technology: Immunoassay, Clinical Chemistry, Molecular Diagnostics, Blood Glucose Monitoring, Hematology, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

In vitro Diagnostics Market Outlook 2031

  • The global industry was valued at US$ 91.2 Bn in 2022
  • It is projected to grow at a CAGR of 5.3% from 2023 to 2031 and reach more than US$ 119.7 Bn by the end of 2031

Analysts’ Viewpoint

Increase in prevalence of chronic and infectious diseases, the need for advanced diagnostic tools, and technological advancements, are fueling the in vitro diagnostics (IVD) market size. Furthermore, the demand for accurate and efficient diagnostics is expected to drive market progress.

Technological advancements in IVD spurs the introduction of innovative products and services, enhancing diagnostic capabilities and enabling the development of new diagnostic methods.

Growth in awareness among patients and healthcare professionals about the importance of early and accurate diagnosis is also expected to bolster the in vitro diagnostics market growth.

Increase in focus on healthcare spending and investments in research and development activities by both public and private sectors are likely to further propel the growth of the in vitro diagnostics market.

Market Introduction

The in vitro diagnostics market is rapidly growing and encompasses products and services for testing bodily samples outside the body to facilitate medical diagnoses. In terms of product & service, the market can be divided into three categories: reagents & kits, instruments, and software & services.

Reagents & kits are essential components used in diagnostic tests, while instruments are physical tools required for accurate and efficient testing. Software & services play a crucial role in data management, analysis, and reporting of test results.

The market is characterized by diverse technologies such as immunoassay, clinical chemistry, molecular diagnostics, blood glucose monitoring, and hematology, catering to various medical needs. Clinical chemistry methods analyze blood and bodily fluids to assess chemical components.

Molecular diagnostics examine genetic material to detect diseases at a molecular level, providing valuable insights into personalized healthcare. Blood glucose monitoring is crucial for managing diabetes, while hematology focuses on blood-related disorders and abnormalities, offering diagnostic tools for conditions including anemia and leukemia.

The in vitro diagnostics market serves a wide range of end-users, including diagnostic centers, hospital-based laboratories, academic & research institutes, home care services, and other healthcare providers.

This diverse range of end-users highlights the widespread impact and importance of the in-vitro diagnostics market in the healthcare ecosystem.

Attribute Detail
Drivers
  • Advancements in In Vitro Diagnostics
  • Growth of Personalized Medicine

Advancements in In Vitro Diagnostics Enhancing Disease Detection and Treatment

In vitro diagnostics (IVDs) play a significant role in healthcare, contributing to 70% of clinical decisions. Technological advancements, such as 3D printing and genomics, have improved diagnostic capabilities.

Predictive biomarkers assist physicians in predicting drug responses and optimizing treatment plans. Point-of-care testing (POCT) offers faster turnaround times and lower costs. Microfluidics, utilizing materials such as PDMS, provide low-volume analysis, high-throughput, automation, and portability.

Innovative technologies such as RT-PCR and next-generation sequencing offer cost-effective diagnosis, prognosis, and therapy selection. Thus, rapid advancements in technology is expected to bolster the in vitro diagnostics industry growth.

Growth of Personalized Medicine Boosting In Vitro Diagnostics Market Revenue

The rise of personalized medicine is an innovative approach that tailors medical treatments to individual patients, considering factors such as genetics, lifestyle, and environment.

Personalized medicine has surged the demand for advanced diagnostic solutions, especially in oncology, where genetic and molecular profiling helps identify tumor biomarkers. Technological advancements including Next-Generation Sequencing (NGS) contribute to disease diagnosis and treatment selection.

Companion diagnostics, which identify patients likely to benefit from specific therapies is a key factor driving the in vitro diagnostics market value. As healthcare shifts toward patient-centric approaches, the IVD industry plays a crucial role in shaping personalized medicine.

Shift to Point-of-Care Diagnostics Fueling Market Expansion

The in vitro diagnostics market is expanding due to patient preference for testing at physician's clinics or homes (point-of-care testing). Intersegment substitution, such as molecular point-of-care diagnostics, is further accelerating market development.

Companies including Autonomous Medical Devices Incorporated (AMDI) and Proxim Diagnostics are developing innovative systems for rapid, accurate testing.

AMDI received a US$ 5.3 Mn grant to create a fast PCR system detecting multiple targets, while Proxim secured investment for its portable immunodiagnostic device.

The Covid-19 pandemic further increased the importance of point-of-care diagnostics, with the market projected to reach US$ 38.5 Bn by 2030.

Healthcare Awareness Driving Demand for Reagents & Kits

The in vitro diagnostics market segmentation by product & service includes reagents & kits, instruments, and software & services. The reagents segment dominated the market in 2022.

The large-scale requirements of diagnostic labs, research centers, and Contract Research Organizations (CROs) is leading to the dominance of reagents & kits. The surge in demand for in vitro assays in pathological analysis and the continuous advancements in diagnostic techniques are also major market catalysts.

Furthermore, expansion of the reagents segment and ongoing technological developments within the industry are expected to offer lucrative in vitro diagnostics market opportunities.

Clinical Chemistry Gaining Traction

The in vitro diagnostics industry report reveals that the market is likely to flourish in the near future due to advancements in technology and increasing prevalence of chronic disorders and infectious diseases.

Based on technology, the clinical chemistry segment's dominance in the market highlights its significance in disease diagnosis and patient management across various healthcare settings. The segment's growth is driven by the continuous development of innovative diagnostic tools and techniques.

Growth of the immunoassay segment is attributed to the extensive research and development activities that are being carried out in this field, leading to the launch of more accurate and efficient diagnostic tests.

The molecular diagnostics segment also is poised for significant expansion during the forecast period, credited to the rise in prevalence of chronic disorders and infectious diseases, which necessitates the development of advanced diagnostic methods to accurately identify and manage these conditions.

Regional Outlook of In Vitro diagnostics Industry

Attribute Detail
Leading Region North America

As per the latest in vitro diagnostics market forecast, North America dominated the global industry in 2022. A robust healthcare infrastructure, high healthcare expenditure, and strong government support for research and development creates a favorable environment for the industry in the region.

Furthermore, the presence of major IVD companies and technological advancements boosts market dynamics in the region.

The large patient population, surge in demand for advanced diagnostic technologies, and rise in prevalence of chronic diseases further drives market statistics, ensuring North America's leading position in the IVD market.

Analysis of Key Players

Leading players have adopted strategies such as development of diagnostic kits and launching new kits to increase their in vitro diagnostics market share.

Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton, Dickinson, and Company, QIAGEN N.V., bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Chembio Diagnostics, Inc., Sysmex Corporation, QuidelOrtho Corporation, and Illumina, Inc. are the prominent in vitro diagnostics market manufacturers.

Key players have been profiled in the global in vitro diagnostics market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In November 2023, Roche introduced Elecsys® HBeAg quant, an immunoassay that can detect the presence and quantity of hepatitis B antigen in human serum and plasma. This test can serve as an early marker of acute hepatitis B infection and indicate chronic active hepatitis. The test simplifies patient management and allows for the most appropriate treatment plan.
  • In July 2023, Beckman Coulter received FDA clearance for its DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer designed for small-to-medium-sized laboratories. The automated analyzer is part of several recent solutions by Beckman Coulter, which optimize laboratory workflows and support critical clinical decisions.

Global In Vitro Diagnostics Market Snapshot

Attribute Detail
Market Value in 2022 US$ 91.2 Bn
Forecast (Value) in 2031 US$ 119.7 Bn
Growth Rate (CAGR) 5.3%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Units US$ Bn for Value
Market Analysis It provides segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product & Service
    • Reagents & Kits
    • Instruments
    • Software & Services
  • Technology
    • Immunoassay
      • ELISA
      • ELISPOT
      • Rapid Test
      • Others (RIA, etc.)
    • Clinical Chemistry
      • Metabolic Panel
      • Electrolyte Panel
      • Liver Panel
      • Lipid Profile
      • Renal Profile
      • Thyroid Function Panel
    • Molecular Diagnostics
      • PCR
      • Isothermal Nucleic Acid Amplification Technology
      • Microarray
      • Hybridization
      • DNA Sequencing & Next-Generation Sequencing
    • Blood Glucose Monitoring
    • Hematology
    • Others (Mass Spectrometry, etc.)
  • Application
    • Oncology
    • Infectious Diseases
    • Metabolic Diseases
    • Cardiology
    • Nephrology
    • Drug Testing/Pharmacogenomics
    • Autoimmune Diseases
    • Others
  • End-user
    • Diagnostic Centers
    • Hospital-based Laboratories
    • Academic & Research Institutes
    • Home care
    • Others
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson, and Company
  • QIAGEN N.V.
  • bioMérieux SA
  • Siemens Healthineers
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostics, Inc.
  • Sysmex Corporation
  • QuidelOrtho Corporation
  • Illumina, Inc.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global in vitro diagnostics market in 2022?

It was valued at US$ 91.2 Bn in 2022

How big will the in vitro diagnostics business be by 2031?

It is projected to reach more than US$ 119.7 Bn by the end of 2031

What will be the CAGR of the in vitro diagnostics industry during the forecast period (2023-2031)?

The CAGR is projected to be 5.3% from 2023 to 2031

Which are the key trends driving demand for in vitro diagnostics?

Increase in incidence and prevalence of chronic disease and advanced diagnostic technology

Which region is likely to account for major share of the in vitro diagnostics sector during the forecast period?

North America is projected to account for major share during the forecast period

Who are the prominent in vitro diagnostics vendors?

Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton, Dickinson, and Company, QIAGEN N.V., bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Chembio Diagnostics, Inc., Sysmex Corporation, QuidelOrtho Corporation, and Illumina, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global In Vitro Diagnostics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global In Vitro Diagnostics Market Analysis and Forecasts, 2017-2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Regulatory Scenario

        5.3. Price Analysis

        5.4. Top Player Positioning

        5.5. Covid-19 Pandemic Impact on Industry

    6. Global In Vitro Diagnostics Market Analysis and Forecasts, By Product & Service

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast By Product & Service, 2017-2031

            6.3.1. Reagents & Kits

            6.3.2. Instruments

            6.3.3. Software & Services

        6.4. Market Attractiveness By Product & Service

    7. Global In Vitro Diagnostics Market Analysis and Forecasts, By Technology

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast By Technology, 2017-2031

            7.3.1. Clinical Chemistry

                7.3.1.1. Metabolic Panel

                7.3.1.2. Electrolyte Panel

                7.3.1.3. Liver Panel

                7.3.1.4. Lipid Profile

                7.3.1.5. Renal Profile

                7.3.1.6. Thyroid Function Panel

            7.3.2. Immunoassay

                7.3.2.1. ELISA

                7.3.2.2. ELISPOT

                7.3.2.3. Rapid Test

                7.3.2.4. Others

            7.3.3. Molecular Diagnostics

                7.3.3.1. PCR

                7.3.3.2. Isothermal Nucleic Acid Amplification Technology

                7.3.3.3. Microarray

                7.3.3.4. Hybridization

                7.3.3.5. DNA Sequencing & Next-Generation Sequencing

            7.3.4. Blood Glucose Monitoring

            7.3.5. Hematology

            7.3.6. Others (Mass Spectrometry, etc.)

        7.4. Market Attractiveness By Technology

    8. Global In Vitro Diagnostics Market Analysis and Forecasts, By Application

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast By Application, 2017-2031

            8.3.1. Oncology

            8.3.2. Infectious Diseases

            8.3.3. Metabolic Diseases

            8.3.4. Cardiology

            8.3.5. Nephrology

            8.3.6. Drug Testing/pharmacogenomics

            8.3.7. Autoimmune Diseases

            8.3.8. Others

        8.4. Market Attractiveness By Application

    9. Global In Vitro Diagnostics Market Analysis and Forecasts, By End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast By End-user, 2017-2031

            9.3.1. Diagnostic Centers

            9.3.2. Hospital-based Laboratories

            9.3.3. Academic & Research Institutes

            9.3.4. Home care

            9.3.5. Others

        9.4. Market Attractiveness By End-user

    10. Global In Vitro Diagnostics Market Analysis and Forecasts, By Region

        10.1. Key Findings

        10.2. Market Value Forecast By Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness By Country/Region

    11. North America In Vitro Diagnostics Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast By Product & Service, 2017-2031

            11.2.1. Reagents & Kits

            11.2.2. Instruments

            11.2.3. Software & Services

        11.3. Market Value Forecast By Technology, 2017-2031

            11.3.1. Clinical Chemistry

                11.3.1.1. Metabolic Panel

                11.3.1.2. Electrolyte Panel

                11.3.1.3. Liver Panel

                11.3.1.4. Lipid Profile

                11.3.1.5. Renal Profile

                11.3.1.6. Thyroid Function Panel

            11.3.2. Immunoassay

                11.3.2.1. ELISA

                11.3.2.2. ELISPOT

                11.3.2.3. Rapid Test

                11.3.2.4. Others

            11.3.3. Molecular Diagnostics

                11.3.3.1. PCR

                11.3.3.2. Isothermal Nucleic Acid Amplification Technology

                11.3.3.3. Microarray

                11.3.3.4. Hybridization

                11.3.3.5. DNA Sequencing & Next-Generation Sequencing

            11.3.4. Blood Glucose Monitoring

            11.3.5. Hematology

            11.3.6. Others (Mass Spectrometry, etc.)

        11.4. Market Value Forecast By Application, 2017-2031

            11.4.1. Oncology

            11.4.2. Infectious Diseases

            11.4.3. Metabolic Diseases

            11.4.4. Cardiology

            11.4.5. Nephrology

            11.4.6. Drug Testing/pharmacogenomics

            11.4.7. Autoimmune Diseases

            11.4.8. Others

        11.5. Market Value Forecast By End-user, 2017-2031

            11.5.1. Diagnostic Centers

            11.5.2. Hospital-based Laboratories

            11.5.3. Academic & Research Institutes

            11.5.4. Home care

            11.5.5. Others

        11.6. Market Value Forecast By Country/Sub-region, 2017-2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Product & Service

            11.7.2. By Technology

            11.7.3. By Application

            11.7.4. By End-user

            11.7.5. By Country/Sub-region

    12. Europe In Vitro Diagnostics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast By Product & Service, 2017-2031

            12.2.1. Reagents & Kits

            12.2.2. Instruments

            12.2.3. Software & Services

        12.3. Market Value Forecast By Technology, 2017-2031

            12.3.1. Clinical Chemistry

                12.3.1.1. Metabolic Panel

                12.3.1.2. Electrolyte Panel

                12.3.1.3. Liver Panel

                12.3.1.4. Lipid Profile

                12.3.1.5. Renal Profile

                12.3.1.6. Thyroid Function Panel

            12.3.2. Immunoassay

                12.3.2.1. ELISA

                12.3.2.2. ELISPOT

                12.3.2.3. Rapid Test

                12.3.2.4. Others

            12.3.3. Molecular Diagnostics

                12.3.3.1. PCR

                12.3.3.2. Isothermal Nucleic Acid Amplification Technology

                12.3.3.3. Microarray

                12.3.3.4. Hybridization

                12.3.3.5. DNA Sequencing & Next-Generation Sequencing

            12.3.4. Blood Glucose Monitoring

            12.3.5. Hematology

            12.3.6. Others (Mass Spectrometry, etc.)

        12.4. Market Value Forecast By Application, 2017-2031

            12.4.1. Oncology

            12.4.2. Infectious Diseases

            12.4.3. Metabolic Diseases

            12.4.4. Cardiology

            12.4.5. Nephrology

            12.4.6. Drug Testing/pharmacogenomics

            12.4.7. Autoimmune Diseases

            12.4.8. Others

        12.5. Market Value Forecast By End-user, 2017-2031

            12.5.1. Diagnostic Centers

            12.5.2. Hospital-based Laboratories

            12.5.3. Academic & Research Institutes

            12.5.4. Home care

            12.5.5. Others

        12.6. Market Value Forecast By Country/Sub-region, 2017-2031

            12.6.1. Germany

            12.6.2. UK

            12.6.3. France

            12.6.4. Italy

            12.6.5. Spain

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Product & Service

            12.7.2. By Technology

            12.7.3. By Application

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast By Product & Service, 2017-2031

            13.2.1. Reagents & Kits

            13.2.2. Instruments

            13.2.3. Software & Services

        13.3. Market Value Forecast By Technology, 2017-2031

            13.3.1. Clinical Chemistry

                13.3.1.1. Metabolic Panel

                13.3.1.2. Electrolyte Panel

                13.3.1.3. Liver Panel

                13.3.1.4. Lipid Profile

                13.3.1.5. Renal Profile

                13.3.1.6. Thyroid Function Panel

            13.3.2. Immunoassay

                13.3.2.1. ELISA

                13.3.2.2. ELISPOT

                13.3.2.3. Rapid Test

                13.3.2.4. Others

            13.3.3. Molecular Diagnostics

                13.3.3.1. PCR

                13.3.3.2. Isothermal Nucleic Acid Amplification Technology

                13.3.3.3. Microarray

                13.3.3.4. Hybridization

                13.3.3.5. DNA Sequencing & Next-Generation Sequencing

            13.3.4. Blood Glucose Monitoring

            13.3.5. Hematology

            13.3.6. Others (Mass Spectrometry, etc.)

        13.4. Market Value Forecast By Application, 2017-2031

            13.4.1. Oncology

            13.4.2. Infectious Diseases

            13.4.3. Metabolic Diseases

            13.4.4. Cardiology

            13.4.5. Nephrology

            13.4.6. Drug Testing/pharmacogenomics

            13.4.7. Autoimmune Diseases

            13.4.8. Others

        13.5. Market Value Forecast By End-user, 2017-2031

            13.5.1. Diagnostic Centers

            13.5.2. Hospital-based Laboratories

            13.5.3. Academic & Research Institutes

            13.5.4. Home care

            13.5.5. Others

        13.6. Market Value Forecast By Country/Sub-region, 2017-2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. By Product & Service

            13.7.2. By Technology

            13.7.3. By Application

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Latin America In Vitro Diagnostics Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast By Product & Service, 2017-2031

            14.2.1. Reagents & Kits

            14.2.2. Instruments

            14.2.3. Software & Services

        14.3. Market Value Forecast By Technology, 2017-2031

            14.3.1. Clinical Chemistry

                14.3.1.1. Metabolic Panel

                14.3.1.2. Electrolyte Panel

                14.3.1.3. Liver Panel

                14.3.1.4. Lipid Profile

                14.3.1.5. Renal Profile

                14.3.1.6. Thyroid Function Panel

            14.3.2. Immunoassay

                14.3.2.1. ELISA

                14.3.2.2. ELISPOT

                14.3.2.3. Rapid Test

                14.3.2.4. Others

            14.3.3. Molecular Diagnostics

                14.3.3.1. PCR

                14.3.3.2. Isothermal Nucleic Acid Amplification Technology

                14.3.3.3. Microarray

                14.3.3.4. Hybridization

                14.3.3.5. DNA Sequencing & Next-Generation Sequencing

            14.3.4. Blood Glucose Monitoring

            14.3.5. Hematology

            14.3.6. Others (Mass Spectrometry, etc.)

        14.4. Market Value Forecast By Application, 2017-2031

            14.4.1. Oncology

            14.4.2. Infectious Diseases

            14.4.3. Metabolic Diseases

            14.4.4. Cardiology

            14.4.5. Nephrology

            14.4.6. Drug Testing/pharmacogenomics

            14.4.7. Autoimmune Diseases

            14.4.8. Others

        14.5. Market Value Forecast By End-user, 2017-2031

            14.5.1. Diagnostic Centers

            14.5.2. Hospital-based Laboratories

            14.5.3. Academic & Research Institutes

            14.5.4. Home care

            14.5.5. Others

        14.6. Market Value Forecast By Country/Sub-region, 2017-2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. By Product & Service

            14.7.2. By Technology

            14.7.3. By Application

            14.7.4. By End-user

            14.7.5. By Country/Sub-region

    15. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast By Product & Service, 2017-2031

            15.2.1. Reagents & Kits

            15.2.2. Instruments

            15.2.3. Software & Services

        15.3. Market Value Forecast By Technology, 2017-2031

            15.3.1. Clinical Chemistry

                15.3.1.1. Metabolic Panel

                15.3.1.2. Electrolyte Panel

                15.3.1.3. Liver Panel

                15.3.1.4. Lipid Profile

                15.3.1.5. Renal Profile

                15.3.1.6. Thyroid Function Panel

            15.3.2. Immunoassay

                15.3.2.1. ELISA

                15.3.2.2. ELISPOT

                15.3.2.3. Rapid Test

                15.3.2.4. Others

            15.3.3. Molecular Diagnostics

                15.3.3.1. PCR

                15.3.3.2. Isothermal Nucleic Acid Amplification Technology

                15.3.3.3. Microarray

                15.3.3.4. Hybridization

                15.3.3.5. DNA Sequencing & Next-Generation Sequencing

            15.3.4. Blood Glucose Monitoring

            15.3.5. Hematology

            15.3.6. Others (Mass Spectrometry, etc.)

        15.4. Market Value Forecast By Application, 2017-2031

            15.4.1. Oncology

            15.4.2. Infectious Diseases

            15.4.3. Metabolic Diseases

            15.4.4. Cardiology

            15.4.5. Nephrology

            15.4.6. Drug Testing/pharmacogenomics

            15.4.7. Autoimmune Diseases

            15.4.8. Others

        15.5. Market Value Forecast By End-user, 2017-2031

            15.5.1. Diagnostic Centers

            15.5.2. Hospital-based Laboratories

            15.5.3. Academic & Research Institutes

            15.5.4. Home care

            15.5.5. Others

        15.6. Market Value Forecast By Country/Sub-region, 2017-2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Market Attractiveness Analysis

            15.7.1. By Product & Service

            15.7.2. By Technology

            15.7.3. By Application

            15.7.4. By End-user

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (By Tier and Size of companies)

        16.2. Company Profiles

            16.2.1. Danaher Corporation

                16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.1.2. Product Portfolio

                16.2.1.3. Financial Overview

                16.2.1.4. SWOT Analysis

                16.2.1.5. Strategic Overview

            16.2.2. F. Hoffmann-La Roche Ltd.

                16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.2.2. Product Portfolio

                16.2.2.3. Financial Overview

                16.2.2.4. SWOT Analysis

                16.2.2.5. Strategic Overview

            16.2.3. Thermo Fisher Scientific Inc.

                16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.3.2. Product Portfolio

                16.2.3.3. Financial Overview

                16.2.3.4. SWOT Analysis

                16.2.3.5. Strategic Overview

            16.2.4. Becton, Dickinson, and Company

                16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.4.2. Product Portfolio

                16.2.4.3. Financial Overview

                16.2.4.4. SWOT Analysis

                16.2.4.5. Strategic Overview

            16.2.5. QIAGEN N.V.

                16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.5.2. Product Portfolio

                16.2.5.3. Financial Overview

                16.2.5.4. SWOT Analysis

                16.2.5.5. Strategic Overview

            16.2.6. bioMérieux SA

                16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.6.2. Product Portfolio

                16.2.6.3. Financial Overview

                16.2.6.4. SWOT Analysis

                16.2.6.5. Strategic Overview

            16.2.7. Siemens Healthcare GmbH

                16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.7.2. Product Portfolio

                16.2.7.3. Financial Overview

                16.2.7.4. SWOT Analysis

                16.2.7.5. Strategic Overview

            16.2.8. Abbott Laboratories

                16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.8.2. Product Portfolio

                16.2.8.3. Financial Overview

                16.2.8.4. SWOT Analysis

                16.2.8.5. Strategic Overview

            16.2.9. Agilent Technologies, Inc.

                16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.9.2. Product Portfolio

                16.2.9.3. Financial Overview

                16.2.9.4. SWOT Analysis

                16.2.9.5. Strategic Overview

            16.2.10. Bio-Rad Laboratories, Inc.

                16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.10.2. Product Portfolio

                16.2.10.3. Financial Overview

                16.2.10.4. SWOT Analysis

                16.2.10.5. Strategic Overview

            16.2.11. Chembio Diagnostics, Inc.

                16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.11.2. Product Portfolio

                16.2.11.3. Financial Overview

                16.2.11.4. SWOT Analysis

                16.2.11.5. Strategic Overview

            16.2.12. Sysmex Corporation

                16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.12.2. Product Portfolio

                16.2.12.3. Financial Overview

                16.2.12.4. SWOT Analysis

                16.2.12.5. Strategic Overview

            16.2.13. QuidelOrtho Corporation.

                16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.13.2. Product Portfolio

                16.2.13.3. Financial Overview

                16.2.13.4. SWOT Analysis

                16.2.13.5. Strategic Overview

            16.2.14. Illumina, Inc.

                16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.2.14.2. Product Portfolio

                16.2.14.3. Financial Overview

                16.2.14.4. SWOT Analysis

                16.2.14.5. Strategic Overview

    List of Tables

    Table 01: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031

    Table 02: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 03: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 04: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 05: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031

    Table 06: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031

    Table 07: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031

    Table 08: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 09: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031

    Table 10: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031

    Table 11: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031

    Table 12: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 13: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 14: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 15: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031

    Table 16: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 17: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031

    Table 18: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031

    Table 19: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031

    Table 20: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 21: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 22: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 23: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031

    Table 24: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 25: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031

    Table 26: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031

    Table 27: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031

    Table 28: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 29: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 30: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 31: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031

    Table 32: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 33: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031

    Table 34: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031

    Table 35: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031

    Table 36: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 37: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 38: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

    Table 39: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031

    Table 40: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031

    Table 41: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031

    Table 42: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031

    Table 43: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031

    Table 44: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 45: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global In Vitro Diagnostics Market Size, by Product & Service, 2022

    Figure 02: In Vitro Diagnostics Market share (%), by Product & Service, 2022

    Figure 03: In Vitro Diagnostics Market Size, by Technology, 2022

    Figure 04: In Vitro Diagnostics Market share (%), by Technology, 2022

    Figure 05: In Vitro Diagnostics Market Size, by Application, 2022

    Figure 06: In Vitro Diagnostics Market share (%), by Application, 2022

    Figure 07: In Vitro Diagnostics Market Size, by End-User, 2022

    Figure 08: In Vitro Diagnostics Market share (%), by End-User, 2022

    Figure 09: Global In Vitro Diagnostics Market, By Region (2022 and 2031)

    Figure 10: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, 2017-2031

    Figure 11: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031

    Figure 12: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022

    Figure 13: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2031

    Figure 14: Global In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031

    Figure 15: Global In Vitro Diagnostics Market Value (US$ Mn), by Reagents & Kits, 2017-2031

    Figure 16: Global In Vitro Diagnostics Market Value Share Analysis, by Reagents & Kits, 2022 and 2031

    Figure 17: Global In Vitro Diagnostics Market Value (US$ Mn), by Instruments, 2017-2031

    Figure 18: Global In Vitro Diagnostics Market Value Share Analysis, Instruments, 2022 and 2031

    Figure 19: Global In Vitro Diagnostics Market Value (US$ Mn), by Software & Services, 2017-2031

    Figure 20: Global In Vitro Diagnostics Market Value Share Analysis, by Software & Services, 2022 and 2031

    Figure 21: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 22: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022

    Figure 23: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2031

    Figure 24: Global In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031

    Figure 25: Global In Vitro Diagnostics Market Value (US$ Mn), by Immunoassay, 2017-2031

    Figure 26: Global In Vitro Diagnostics Market Value Share Analysis, by Immunoassay, 2022 and 2031

    Figure 27: Global In Vitro Diagnostics Market Value (US$ Mn), by Clinical Chemistry, 2017-2031

    Figure 28: Global In Vitro Diagnostics Market Value Share Analysis, Clinical Chemistry, 2022 and 2031

    Figure 29: Global In Vitro Diagnostics Market Value (US$ Mn), by Molecular Diagnostics, 2017-2031

    Figure 30: Global In Vitro Diagnostics Market Value Share Analysis, by Molecular Diagnostics, 2022 and 2031

    Figure 31: Global In Vitro Diagnostics Market Value (US$ Mn), by Blood Glucose Monitoring, 2017-2031

    Figure 32: Global In Vitro Diagnostics Market Value Share Analysis, Blood Glucose Monitoring, 2022 and 2031

    Figure 33: Global In Vitro Diagnostics Market Value (US$ Mn), by Hematology, 2017-2031

    Figure 34: Global In Vitro Diagnostics Market Value Share Analysis, by Molecular Diagnostics, 2022 and 2031

    Figure 35: Global In Vitro Diagnostics Market Value (US$ Mn), by Others, 2017-2031

    Figure 36: Global In Vitro Diagnostics Market Value Share Analysis, Blood Glucose Monitoring, 2022 and 2031

    Figure 37: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 38: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2022

    Figure 39: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2031

    Figure 40: Global In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

    Figure 41: Global In Vitro Diagnostics Market Value (US$ Mn), by Oncology, 2017-2031

    Figure 42: Global In Vitro Diagnostics Market Value Share Analysis, by Oncology, 2022 and 2031

    Figure 43: Global In Vitro Diagnostics Market Value (US$ Mn), by Infectious Diseases, 2017-2031

    Figure 44: Global In Vitro Diagnostics Market Value Share Analysis, Infectious Diseases, 2022 and 2031

    Figure 45: Global In Vitro Diagnostics Market Value (US$ Mn), by Metabolic Diseases, 2017-2031

    Figure 46: Global In Vitro Diagnostics Market Value Share Analysis, by Metabolic Diseases, 2022 and 2031

    Figure 47: Global In Vitro Diagnostics Market Value (US$ Mn), by Cardiology, 2017-2031

    Figure 48: Global In Vitro Diagnostics Market Value Share Analysis, Cardiology, 2022 and 2031

    Figure 49: Global In Vitro Diagnostics Market Value (US$ Mn), by Nephrology, 2017-2031

    Figure 50: Global In Vitro Diagnostics Market Value Share Analysis, by Nephrology, 2022 and 2031

    Figure 51 Global In Vitro Diagnostics Market Value (US$ Mn), by Drug Testing/Pharmacogenomics, 2017-2031

    Figure 52: Global In Vitro Diagnostics Market Value Share Analysis, Drug Testing/pharmacogenomics, 2022 and 2031

    Figure 53: Global In Vitro Diagnostics Market Value (US$ Mn), by Autoimmune Diseases, 2017-2031

    Figure 54: Global In Vitro Diagnostics Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031

    Figure 55: Global In Vitro Diagnostics Market Value (US$ Mn), by Others, 2017-2031

    Figure 56: Global In Vitro Diagnostics Market Value Share Analysis, Others, 2022 and 2031

    Figure 57: Global In Vitro Diagnostics Market Value Share Analysis, by End-User, 2022 and 2031

    Figure 58: Global In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022

    Figure 59: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2031

    Figure 60: Global In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 61: Global In Vitro Diagnostics Market Value (US$ Mn), by Diagnostic Centers, 2017-2031

    Figure 62: Global In Vitro Diagnostics Market Value Share Analysis, by Diagnostic Centers, 2022 and 2031

    Figure 63: Global In Vitro Diagnostics Market Value (US$ Mn), by Hospital-based Laboratories, 2017-2031

    Figure 64: Global In Vitro Diagnostics Market Value Share Analysis, Hospital-based Laboratories, 2022 and 2031

    Figure 65: Global In Vitro Diagnostics Market Value (US$ Mn), by Academic & Research Institutes, 2017-2031

    Figure 66: Global In Vitro Diagnostics Market Value Share Analysis, by Academic & Research Institutes, 2022 and 2031

    Figure 67: Global In Vitro Diagnostics Market Value (US$ Mn), by Home care, 2017-2031

    Figure 68: Global In Vitro Diagnostics Market Value Share Analysis, Home care, 2022 and 2031

    Figure 69: Global In Vitro Diagnostics Market Value Share Analysis, by Region, 2022 and 2031

    Figure 70: Global In Vitro Diagnostics Market Attractiveness Analysis, by Region, 2023-2031

    Figure 71: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 72: North America In Vitro Diagnostics Market Value Share Analysis, by Country, 2022 and 2031

    Figure 73: North America In Vitro Diagnostics Market Attractiveness Analysis, by Country, 2023-2031

    Figure 74: North America In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031

    Figure 75: North America In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031

    Figure 76: North America In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 77: North America In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 78: North America In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 79: North America In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

    Figure 80: North America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 81: North America In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 82: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 83: Europe In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 84: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 85: Europe In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031

    Figure 86: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031

    Figure 87: Europe In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 88: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 89: Europe In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 90: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

    Figure 91: Europe In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 92: Europe In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 93: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 94: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 95: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 96: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031

    Figure 97: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031

    Figure 98: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 99: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 100: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 101: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

    Figure 102: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 103: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 104: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 105: Latin America In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 106: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 107: Latin America In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031

    Figure 108: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031

    Figure 109: Latin America In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 110: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 111: Latin America In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 112: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

    Figure 113: Latin America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 114: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

    Figure 115: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

    Figure 116: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 117: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 118: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031

    Figure 119: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031

    Figure 120: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031

    Figure 121: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031

    Figure 122: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031

    Figure 123: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031

    Figure 124: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031

    Figure 125: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved